Newtyn Management’s Atea Pharmaceuticals AVIR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.09M | Hold |
580,000
| – | – | 0.32% | 32 |
|
|
2025
Q1 | $1.73M | Hold |
580,000
| – | – | 0.27% | 28 |
|
|
2024
Q4 | $1.94M | Buy |
580,000
+200,000
| +53% | +$670K | 0.34% | 29 |
|
|
2024
Q3 | $1.27M | Hold |
380,000
| – | – | 0.2% | 37 |
|
|
2024
Q2 | $1.26M | Sell |
380,000
-20,000
| -5% | -$66.2K | 0.24% | 34 |
|
|
2024
Q1 | $1.62M | Sell |
400,000
-108,474
| -21% | -$438K | 0.32% | 33 |
|
|
2023
Q4 | $1.55M | Buy |
508,474
+108,474
| +27% | +$331K | 0.3% | 35 |
|
|
2023
Q3 | $1.2M | Buy |
400,000
+310,803
| +348% | +$932K | 0.3% | 37 |
|
|
2023
Q2 | $334K | Buy |
+89,197
| New | +$334K | 0.08% | 40 |
|